ABSR Laboratories Achieves Breakthrough in Digestive Health

Mumbai, India - ABSR Laboratories Private Limited is thrilled to announce a groundbreaking discovery by its Chief Scientist, Shibanjan Paul Roy. He has successfully developed a novel digestive enzyme syrup with potent anti-ulcer activities, demonstrating rapid healing properties.

This innovative syrup shows tremendous potential in treating digestive disorders, offering new hope for patients suffering from ulcers and other gastrointestinal issues. The discovery is expected to revolutionize gastroenterology and provide a cutting-edge solution for digestive health.

Further Details:
• Syrup Composition: Unknown
• Clinical Trials: Ongoing trials show significant efficacy in healing ulcers and improving digestive health
• Patent Status: Patent application filed to protect this innovative discovery

ABSR Laboratories looks forward to bringing this life-changing treatment to patients worldwide.

A multi-functional, patented formulation for diabetic wounds, minor cuts, burns, pain relief, and antifungal protection.

Helps in faster healing, pain relief, and infection control — suitable for burns, wounds, and fungal infections.

Clinically tested to protect and regenerate skin cells for diabetic patients and injury recovery.

Trusted by doctors for external wound management — combines anti-inflammatory and antifungal benefits.